Latest Commercialization News

Resolution Minerals appoints Dr Adam Roper as Chief Metallurgist to advance antimony, tungsten, and gold processing at its Idaho Horse Heaven Project, aligning with US defense supply chain goals.

Prescient Therapeutics has secured European authorization to initiate a Phase 2a clinical trial of its novel cancer drug PTX-100 for relapsed/refractory Cutaneous T-cell Lymphoma, enabling trial site activation in Italy.

Orthocell has lodged a regulatory application to distribute its nerve repair product Remplir™ across the EU and UK, aiming to tap into a $750 million market with approval expected by Q3 2026.

Neuren Pharmaceuticals’ partner Acadia secures FDA approval for DAYBUE STIX, a new powder formulation of trofinetide offering greater flexibility for Rett syndrome patients. This milestone expands treatment options and sets the stage for increased royalty revenue in 2026.

Fortifai Limited introduces Nol8, a breakthrough platform that processes data in real time with millisecond latency, promising to transform industries reliant on massive data flows.

Blue Star Helium has completed mechanical assembly of its Galactica helium facility and is set to begin commissioning this week, aiming for first production by December 2025.

Rio Tinto has completed due diligence on Calix’s Zesty Green Iron Demonstration Project, unlocking an initial $3 million investment and moving the venture closer to commercial reality.

Ovanti’s US payments brand Flote has partnered with cloud-native platform Gr4vy to launch scalable, responsible buy now pay later solutions in the US market starting 2026.

Imricor Medical Systems has secured Institutional Review Board approval for the University of Virginia Health to join its VISABL-AFL clinical trial, marking a key expansion in the US. Procedures are set to begin early next year, supporting Imricor’s progress toward FDA approval and commercialisation.

Aurora Labs has signed a landmark MOU with European defence giant MBDA to explore integrating its 3D-printed turbojet engines into advanced missile systems, marking a significant step into international defence markets.

Finder Energy has completed the acquisition of the Petrojarl I FPSO, gaining full control of vital infrastructure for the Kuda Tasi and Jahal project and setting the stage for a Final Investment Decision by mid-2026.

Finder Energy has completed its farmout agreement with Serica Energy, acquiring a 20% interest in the Seaward Production Licence P2530 and continuing as operator during Phase B. The company is now conducting feasibility studies to determine whether to advance to Phase C or discontinue the licence.